The Effectiveness of an Obstructive Sleep Apnea Screening and Treatment Program in Patients With Type 2 Diabetes

Obstructive sleep apnea (OSA) is a highly prevalent condition that is associated with excessive daytime sleepiness, reduced quality of life, hypertension, and increased cardiovascular risk.[1] Patients with type 2 diabetes are at particularly high risk for OSA. The Sleep Heart Health Study, a community-based cohort study, observed a 58% prevalence of OSA among participants with type 2 diabetes. Similarly, in a subset of overweight and obese diabetics participating in the LookAHEAD trial, the prevalence of OSA was over 86%.

Source: Diabetes Research and Clinical Practice - October 17, 2017 Category: Endocrinology Authors: Lucas M. Donovan, Michael Rueschman, Jia Weng, Nisha Basu, Katherine A. Dudley, Jessie P. Bakker, Rui Wang, Suzanne M. Bertisch, Sanjay R. Patel Source Type: research